Skip to main content

Media & Press relations

  

Our latest press releases

Third-quarter 2022 Business Review

bioMérieux, a world leader in the field of in vitro diagnostics, releases its business review for the nine months ended September 30, 2022.

Discover more

Swipe for more

  • Survey bioMérieux OpinionWay - Antimicrobial Resistance and diagnostic tests

    To mark World Antimicrobial Awareness Week organized by the WHO from November 18-24, bioMérieux presents the results of a bioMérieux/OpinionWay survey on the general public's knowledge of antimicrobial resistance and the use of diagnostic tests in France.

    Read more
  • New survey shows low adherence to guidelines in sepsis care puts patients at risk

    To mark Sepsis Awareness Month, bioMérieux, a world leader in in vitro diagnostics with a long-standing commitment to the fight against sepsis, and the UK Sepsis Trust, an internationally renowned charity, have released new survey data of health professionals to assess their knowledge and practice in the management of sepsis. This survey was commissioned among 368 doctors across six European countries.

    Read more
  • First-Half 2022 Results

    The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on August 30 under the chairmanship of Alexandre Mérieux and approved the consolidated financial statements for the six months ended June 30, 2022.

    Read more

Media contacts

Olivier Rescanière

Phone: (+33) (0)4 78 87 20 00 
Email: media@biomerieux.com

_____

Romain Duchez

Phone: (+33) (0)4 78 87 20 00 
Email: media@biomerieux.com


Corporate Library